Difopein is dimeric version of R18 peptidean, and behaves as 14-3-3 protein inhibitor that competitively inhibits 14.3.3-ligand interactions and blocks the ability of 14.3.3 to bind to target proteins such as Raf-1, Bad, ASK1 and exoenzyme S.
Difopein is a synthetic peptide inhibitor renowned for its high-affinity binding to 14-3-3 proteins, a family of regulatory molecules involved in diverse cellular signaling pathways. Structurally, it is designed to disrupt the protein-protein interactions mediated by 14-3-3, making it an essential tool for dissecting the functional roles of these adaptors in phosphorylation-dependent cellular processes. As a research reagent, Difopein provides unique specificity and selectivity, enabling detailed mechanistic studies of signaling networks that depend on 14-3-3 scaffolding. Its application has been pivotal in advancing understanding of cellular regulation, signal transduction, and the molecular underpinnings of various physiological and pathological states.
Signal transduction research: Difopein serves as a powerful molecular probe for investigating 14-3-3-dependent signaling cascades. By competitively inhibiting the interaction between 14-3-3 proteins and their phosphorylated targets, it allows researchers to delineate the impact of these interactions on downstream signaling events. This is particularly valuable for mapping the role of 14-3-3 in pathways such as cell cycle progression, apoptosis, and stress response, providing insights into how cellular outcomes are orchestrated by dynamic protein complexes.
Protein-protein interaction studies: As a selective disruptor of 14-3-3 binding, this peptide is instrumental in characterizing the molecular interfaces involved in protein assembly and recognition. Researchers employ it to validate the functional relevance of predicted 14-3-3 binding motifs in client proteins, assess the consequences of interaction blockade, and elucidate the structural determinants of complex formation. Such studies are critical for understanding the specificity and plasticity of protein networks in cellular regulation.
Functional genomics and proteomics: Difopein enables targeted perturbation of 14-3-3 interactions in cellular and organismal systems, facilitating loss-of-function analyses without the need for genetic manipulation. By introducing the peptide into cells or model organisms, scientists can transiently inhibit 14-3-3 activity and observe resultant phenotypic or proteomic changes. This approach is particularly useful for identifying novel 14-3-3 substrates and for interrogating their roles in diverse biological contexts.
Cellular signaling pathway validation: The peptide's ability to block 14-3-3 interactions is widely utilized to confirm the involvement of these adaptors in specific signaling modules. Researchers can apply it in combination with other biochemical or pharmacological tools to dissect pathway architecture, validate candidate regulatory nodes, and test hypotheses about signal integration and cross-talk. This application is essential for establishing causality in complex signaling networks and for refining models of cellular information processing.
Drug discovery and inhibitor screening: Difopein functions as a benchmark inhibitor in the development and validation of novel compounds targeting 14-3-3-mediated interactions. Its well-characterized binding mode provides a reference for comparative studies, assay calibration, and high-throughput screening efforts aimed at identifying small-molecule modulators of 14-3-3 function. By serving as a positive control or competitor, it enhances the reliability and interpretability of screening data, accelerating the identification of candidate molecules for further research and development.
1. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists
2. The spatiotemporal control of signalling and trafficking of the GLP-1R
4. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
5. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More